Jounce Therapeutics

  • BioTech/Drugs
  • Cambridge MA
  • 59 employees
  • Biotechnology
Get Full Info

Company Overview

Headquarters
780 Memorial Drive, Cambridge MA
Website
jouncetx.com
Email
gr****@jouncetx.com
Phone
(857) 259-3840
Employees
59
Founded in
2013
Industry
BioTech/Drugs
Stock Symbol
NASDAQ:JNC
NAICS Code
NAICS Code 32 Companies
NAICS Code 54 Companies
NAICS Code 54171 Companies
NAICS Code 541 Companies
NAICS Code 5417 Companies
NAICS Code 541712 Companies
NAICS Code 325 Companies
NAICS Code 541711 Companies
SIC Code
SIC Code 873 Companies
SIC Code 87 Companies
SIC Code 283 Companies
SIC Code 28 Companies
More Details

Financials & Stats

Revenue

$25B

Total Funding Amount

$269M

More Financials

Who is Jounce Therapeutics

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company based in Cambridge, Massachusetts. The company employs 59 people and has generated $25.4 million in revenue. Jounce Therapeutics focuses on developing cancer therapies that leverage the power of the immune system to target and destroy tumors. The company's product pipeline includes several promising candidates. JTX-8064, a LILRB2 receptor antagonist, aims to reprogram immune-suppressive cells within tumors to fight cancer. Vopratelimab, a monoclonal antibody targeting ICOS, is being investigated in a Phase 2 clinical trial. JTX-4014, a PD-1 inhibitor, is designed for use in combination with other therapies. Jounce Therapeutics also previously licensed JTX-1811, a monoclonal antibody targeting CCR8, to Gilead Sciences, Inc. Jounce Therapeutics utilizes a biomarker-driven approach to develop its therapies, aiming to provide long-lasting benefits for patients. Their Translational Science Platform drives the discovery and development of new assets within their pipeline. For more information about Jounce Therapeutics and its innovative cancer therapies, please visit www.jouncetx.com.

Jounce Therapeutics Industry Tags

Cancer Immunotherapy
Immunology
Oncology
Antibody Development
B2B
Biotech
SaaS
Commercial Physical Research
Biotechnology
Biotech Pharmaceuticals
View All Industry Tags

Jounce Therapeutics Tech Stack

JavaScript
HTML
PHP
View All Tech Stack

Companies Similar to Jounce Therapeutics

Analyze industry trends and opportunities by examining competitors and companies comparable to Jounce Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in
25M 61 Horsham, PA 1978
25M 96 Northridge, CA 1978
25M 250 San Jose, CA 2005
25M 150 San Diego, CA 1991
25M 37 Worthington, MN
View More Companies

FAQ

What is the location of Jounce Therapeutics's headquarters?
The headquarters of Jounce Therapeutics are situated at 780 Memorial Drive, Cambridge MA
What is Jounce Therapeutics's phone number?
Jounce Therapeutics's contact number is (857) 259-3840.
What stock ticker represents Jounce Therapeutics?
As a publicly traded company, Jounce Therapeutics trades under the symbol NASDAQ:JNC.
What is Jounce Therapeutics's official website?
The official website of Jounce Therapeutics can be found at jouncetx.com.
What is Jounce Therapeutics's current revenue?
As of February 2023, Jounce Therapeutics's annual revenue reached $25B.
How many employees does Jounce Therapeutics currently have?
Jounce Therapeutics employs approximately 59+ people as of February 2023
Which industries is Jounce Therapeutics primarily operating in?
Jounce Therapeutics operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
What are Jounce Therapeutics's industry tags?
Jounce Therapeutics's industry tags include: Cancer Immunotherapy, Immunology, Oncology
What is Jounce Therapeutics's total funding to date?
Jounce Therapeutics has secured $269M as of February 2023
When was Jounce Therapeutics founded?
Jounce Therapeutics was founded in 2013.

Employee Directory

Key Employees

Richard Murray

Chief Executive Officer & President

Phone Email

Dan Felitsky

Principal & Scientist

Phone Email

Haley Laken

Chief Development Officer

Phone Email

Akhila Konda

Product Development and Technical Operations Co-Op

Phone Email

James Rivera

Tier III Support Engineer

Phone Email